eShowcase: Velos eResearch Version 7
New clinical trial software version provides direct data capture at investigator sites
New clinical trial software version provides direct data capture at investigator sites
Velos, Inc. (Fremont, CA) has released Velos eResearch Version 7 for increased features and functions for large investigative sites. Velos eResearch is a clinical trial management software system.
Velos eResearch Version 7 provides direct capture of clinical trial data, eliminating duplicate data entry. This in turn allows the systems used at the site to generate better or higher quality research data, and offer improved efficiency and productivity for investigators and sponsors.
Velos eResearch 7 uses Web 2.0 technology and system design. It features HL7 compliance, support for study administration, clinical data management, adverse event reporting, compliance with industry standards (including CFR Part 11), patient- and study-level architecture, and advanced security to large multi-institutional clinical studies.
Velos, Inc., (510) 739-4010, www.velos.com
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
